戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in centers using intravenous alemtuzumab in simultaneous pancreas kidney transplantation.
2 ility of rapid corticosteroid elimination in simultaneous pancreas kidney transplantation.
3 er cadaveric kidney transplantation alone or simultaneous pancreas-kidney transplantation.
4 rvival, and postsurgical complications after simultaneous pancreas-kidney transplantation.
5  survival rates now no longer trail those of simultaneous pancreas-kidney transplantation.
6 laxis against CMV reactivation in kidney and simultaneous pancreas/kidney transplantation.
7 s azathioprine (AZA) in cyclosporine-treated simultaneous pancreas-kidney transplantations.
8 ere performed in 141 patients, including 126 simultaneous pancreas-kidney transplantations, 13 pancre
9  17 cases, retransplantation in 5 cases, and simultaneous pancreas-kidney transplantation after heart
10 ncreas after kidney transplant, the second a simultaneous pancreas kidney transplantation, and the th
11                          Patients undergoing simultaneous pancreas-kidney transplantation are at risk
12 mediated rejection (AMR) of the kidney after simultaneous pancreas-kidney transplantation are unknown
13 on and its impact on long-term outcome after simultaneous pancreas-kidney transplantation are unknown
14                        This study shows that simultaneous pancreas-kidney transplantation can restore
15                                              Simultaneous pancreas-kidney transplantation has become
16 revalence and severity of hypertension after simultaneous pancreas-kidney transplantation is limited
17 f the perioperative anesthetic management of simultaneous pancreas-kidney transplantation is to maxim
18 V infection on patient and graft survival in simultaneous pancreas-kidney transplantations is unclear
19     On multivariate analysis, pancreas after simultaneous pancreas-kidney transplantation/solitary pa
20                                              Simultaneous pancreas-kidney transplantation (SPK) ameli
21                                              Simultaneous pancreas-kidney transplantation (SPK) may p
22  Fifteen type 1 diabetic patients undergoing simultaneous pancreas-kidney transplantation (SPK) under
23  types of pancreas transplant (PT) including simultaneous pancreas-kidney transplantation (SPK), panc
24 ednisone-based immunosuppressive regimen for simultaneous pancreas-kidney transplantation (SPK).
25                    By category, 61 underwent simultaneous pancreas-kidney transplantation (SPK); 44 u
26 e retrospectively reviewed the records of 76 simultaneous pancreas-kidney transplantations (SPK) and
27                                              Simultaneous pancreas/kidney transplantation (SPK) has e
28                                              Simultaneous pancreas kidney transplantation (SPKT) is t
29 ective analysis of 130 patients submitted to simultaneous pancreas-kidney transplantation (SPKT) and
30            One of the alternative options to simultaneous pancreas-kidney transplantation (SPKT) for
31                                              Simultaneous pancreas-kidney transplantation (SPKT) is a
32                 The best induction agent for simultaneous pancreas-kidney transplantation (SPKT) rema
33 ions (PPFC) are a serious complication after simultaneous pancreas-kidney transplantation (SPKTx).
34 t that hypertension may be less common after simultaneous pancreas-kidney transplantation than after
35 rating time of 3 and 5 hr, respectively; the simultaneous pancreas kidney transplantation took 8 hr.
36                       A total of 620 primary simultaneous pancreas-kidney transplantations were perfo

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。